1. Academic Validation
  2. Design, synthesis and biological evaluation of novel 7-alkylamino substituted benzo[a]phenazin derivatives as dual topoisomerase I/II inhibitors

Design, synthesis and biological evaluation of novel 7-alkylamino substituted benzo[a]phenazin derivatives as dual topoisomerase I/II inhibitors

  • Eur J Med Chem. 2015 Mar 6:92:540-53. doi: 10.1016/j.ejmech.2015.01.024.
Bing-Lei Yao 1 Yan-Wen Mai 1 Shuo-Bin Chen 1 Hua-Ting Xie 1 Pei-Fen Yao 1 Tian-Miao Ou 1 Jia-Heng Tan 1 Hong-Gen Wang 1 Ding Li 1 Shi-Liang Huang 2 Lian-Quan Gu 1 Zhi-Shu Huang 3
Affiliations

Affiliations

  • 1 School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, People's Republic of China.
  • 2 School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, People's Republic of China. Electronic address: lsshsl@mail.sysu.edu.cn.
  • 3 School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, People's Republic of China. Electronic address: ceshzs@mail.sysu.edu.cn.
Abstract

A novel series of benzo[a]phenazin derivatives bearing alkylamino side chains were designed, synthesized and evaluated for their topoisomerases inhibitory activity as well as cytotoxicity against four human Cancer cell lines (HL-60, K-562, HeLa, and A549). These compounds were found to be dual inhibitors of Topoisomerase (Topo) I and Topo II, and exhibited excellent antiproliferative activity, in particular against HL-60 cells with submicromolar IC50 values. Further mechanistic studies showed that this class of compounds acted as Topo I poisons by stabilizing the Topo I-DNA cleavage complexes and Topo II catalytic inhibitors by inhibiting the ATPase activity of hTopo II. Molecular docking studies revealed the binding modes of these compounds for Topo I and Topo II.

Keywords

ATPase catalytic inhibitor; Antitumor; Benzo[a]phenazin derivatives; Topoisomerase I; Topoisomerase II.

Figures